Drug Monitoring, Antipsychotics, with Confirmation, Urine
Also known as: Aripiprazole (Abilify), Brexpiprazole (Rexulti), Cariprazine (Vraylar), Chlorpromazine (Thorazine), Lurasidone (Latuda)
Use
Therapeutic drug monitoring of antipsychotic medications via urine testing provides information on patient adherence, potential diversion, presence of non‑prescribed or illicit drugs, and unexpected variations in drug disposition, all of which can improve clinical decision‑making and patient management. Absence of an expected drug may indicate non‑adherence or diversion, while detection of a non‑prescribed or illicit drug may signal misuse; differences between expected and actual findings may also flag intolerance, drug interactions, or medical factors affecting elimination.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Mass Spectrometry
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
3 mL random urine
Minimum Volume
2 mL
Container
clinical drug test vial; urine collection container
Causes for Rejection
Preserved urine
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
